Anthony Vecchione
Maven Clinic introduces male fertility support tools, Scripta Insights announces a tool to locate cost-effective meds, and XRHealth launches a new platform.
Nyxoah is in the midst of a lawsuit brought on by Inspire Medical Systems alleging infringement of several patents related to its recently-cleared offering, Genio.
The company began trading on Nasdaq under the ticker symbol HTFL, opening at $19.00 per share.
The Conference Board's principal economic policy analyst PJ Tabit says that while the plan is helpful, it is not a comprehensive framework for how to regulate AI.
The acquisition comes amid OpenEvidence's lawsuit alleging that Pathway Medical stole trade secrets, which Pathway has denied.
Cole Zanetti, professor and director of digital health at Rocky Vista University College of Osteopathic Medicine, says AI can address patient safety and support clinical decision-making and personalized medicine.
The company said it plans to develop its new Chai‑2 platform to design, from square one, completely new antibodies for viruses and cancer.
The acquisition will help Datavant transition its manual health records request process to digital.
The new law bans the use of AI for mental health and therapeutic decision-making, but states it can be used for administrative and supplementary support services.
The company intends to partner with healthcare, biopharmaceutical, medical device and diagnostic companies.